Upregulation of the IL-17 signaling pathway facilitates the recruitment of suppressor cells derived from myeloid tissue, promoting angiogenesis, and inhibiting anti-tumor immunity (Holdbrooks et al., 2018). Here, IL17A is linked to neoplasm.